Neoplasia — MCQs

An epidemiologic study of cancer deaths recorded in the last half of the 20th century is conducted. The number of deaths for one particular cancer had increased markedly in developed nations. More than 30% of cancer deaths in men, and more than 24% of cancer deaths in women, were caused by this neoplasm in 1998. In some nations, prevention strategies reduced deaths from this cancer. Which of the following neoplasms was most likely identified by this study?

Q467Easy

Spindle cell carcinoma is a variant of which type of carcinoma?

Q468Easy

Which is the most common cause of cancer-related death?

Q469Easy

Hepatocellular carcinoma is caused by which of the following?

Q470Easy

All of the following are recognized tumor markers except?

Neoplasia Indian Medical PG Practice Questions and MCQs

Question 461: Carcinogenesis of benzopyrene in animals occurs due to all of the following mechanisms except:

A. Epoxide formation
B. p53 activation
C. Cytochrome P450 activation (Correct Answer)
D. Induction of metabolism by Cytochrome P450

Explanation: **Explanation:** The carcinogenesis of polycyclic aromatic hydrocarbons like **Benzopyrene** follows a specific metabolic pathway [3]. Benzopyrene is a **pro-carcinogen**, meaning it is not inherently carcinogenic but requires metabolic conversion into its active form [3],[4]. **Why Option C is the Correct Answer:** The question asks for the mechanism that does **not** occur. **Cytochrome P450 activation (C)** is the correct choice because Cytochrome P450 (specifically CYP1A1) is the **enzyme** that performs the metabolism; the enzyme itself is not "activated" as a mechanism of carcinogenesis [1]. Rather, the enzyme **metabolizes** the benzopyrene into reactive electrophiles [1]. **Analysis of Other Options:** * **Option D (Induction of metabolism):** Benzopyrene undergoes metabolism by the Cytochrome P450 system in the liver and lungs [1]. This is the primary step in its toxification. * **Option A (Epoxide formation):** During metabolism, Cytochrome P450 converts benzopyrene into **Benzopyrene-7,8-dihydrodiol-9,10-epoxide**. This epoxide is the "ultimate carcinogen" that binds covalently to DNA (forming DNA adducts) [1]. * **Option B (p53 activation/mutation):** The DNA adducts formed by the epoxide lead to permanent mutations. In lung cancer associated with tobacco smoke (rich in benzopyrene), there is a characteristic **G to T transversion** in the **TP53 (p53)** gene [2]. While "activation" in some contexts refers to the cellular stress response, in the context of carcinogenesis, it refers to the specific targeting and subsequent functional loss/mutation of the p53 pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Ultimate Carcinogen of Benzopyrene:** Epoxide (specifically 7,8-diol-9,10-epoxide). * **Associated Cancer:** Squamous cell carcinoma of the lung (tobacco smoke) and skin cancer (experimental models) [3]. * **Key Mutation:** G:C to T:A transversions in the p53 gene [2]. * **Enzyme involved:** CYP1A1 (Polymorphisms in this gene increase susceptibility to lung cancer in smokers) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 423-424. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 331-332. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 217-218. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 330-331.

Question 462: Secondary deposits from prostatic carcinoma are commonest in which of the following organs?

A. Bone (Correct Answer)
B. Kidney
C. Liver
D. Brain

Explanation: **Explanation:** Prostatic carcinoma has a unique predilection for hematogenous spread to the axial skeleton. **Bone** is the most common site of distant metastasis [1], [2], occurring in approximately 80-90% of patients with advanced disease. **Why Bone is the Correct Answer:** The primary mechanism for this spread is the **Batson venous plexus**, a valveless vertebral venous system that connects the deep pelvic veins (prostatic venous plexus) to the internal vertebral venous plexuses. This allows retrograde flow of tumor cells directly to the lumbar vertebrae, pelvis, and ribs, bypassing the caval system. Notably, prostate cancer typically produces **osteoblastic (sclerotic) metastases** [1], characterized by increased bone density on X-ray and elevated serum **Alkaline Phosphatase (ALP)** levels [1]. **Why Other Options are Incorrect:** * **Kidney:** While prostate cancer can locally invade the bladder or obstruct the ureters (causing hydronephrosis), it rarely metastasizes to the renal parenchyma. * **Liver & Brain:** These are common sites for many visceral cancers (like lung or colon), but in prostate cancer, visceral metastasis usually occurs much later in the disease progression, long after skeletal involvement has been established. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site of bone metastasis:** Lumbar spine > Proximal femur > Pelvis [1]. * **Nature of Lesion:** Prostate cancer is the classic cause of **osteoblastic** lesions [1]. (Contrast: Multiple myeloma and Breast cancer—though breast can be mixed—are typically osteolytic). * **Tumor Marker:** **PSA (Prostate-Specific Antigen)** is used for screening and monitoring treatment response. * **Histology:** Most are adenocarcinomas; the **Gleason Scoring System** (based on glandular architecture) is the gold standard for grading. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 501-502. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 671-672.

Question 463: Risk of breast cancer is highest in which of the following conditions?

A. Lobular carcinoma in situ (Correct Answer)
B. Proliferative disease without atypia
C. Proliferative disease with atypia
D. Atypical ductal hyperplasia

Explanation: **Explanation:** The risk of developing invasive breast cancer is categorized based on the histological findings of benign or pre-invasive breast lesions [1]. This classification is crucial for determining clinical management. **1. Why Lobular Carcinoma in Situ (LCIS) is correct:** LCIS is considered a **non-obligate precursor** and a significant **risk marker** for invasive carcinoma. It carries the highest relative risk among the options provided (approximately **7 to 10 times** the risk of the general population). Unlike Ductal Carcinoma in Situ (DCIS), LCIS is often multicentric and bilateral, increasing the risk of invasive cancer in *either* breast, not just the site of the biopsy [1]. **2. Analysis of Incorrect Options:** * **Proliferative disease without atypia (Option B):** Includes conditions like epithelial hyperplasia (moderate/florid), sclerosing adenosis, and papillomas. These carry a **mildly increased risk (1.5–2 times)** [1]. * **Proliferative disease with atypia (Option C):** This is a broad category [1]. While it signifies a higher risk than non-atypical lesions, the specific entities under this (like ADH) carry a lower relative risk than LCIS. * **Atypical Ductal Hyperplasia (ADH) (Option D):** This carries a **moderately increased risk (4–5 times)** [1]. While ADH and Atypical Lobular Hyperplasia (ALH) are significant, they do not reach the 7–10x risk threshold associated with LCIS. **High-Yield Clinical Pearls for NEET-PG:** * **Non-proliferative lesions** (e.g., simple cysts, fibrocystic changes without hyperplasia, mild hyperplasia): **No increased risk (1.0x).** * **E-cadherin mutation:** LCIS is characteristically associated with the loss of E-cadherin expression (due to mutations in the *CDH1* gene), leading to the discohesive nature of the cells. * **Bilateral Risk:** LCIS is a marker of "field effect," meaning both breasts are at risk, whereas DCIS is primarily a precursor for ipsilateral invasive ductal carcinoma [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1054-1064.

Question 464: The cell with an increased mitotic rate that resembles the undifferentiated mesenchymal cells of the same origin is:

A. Anaplastic (Correct Answer)
B. Dysplastic
C. Metaplastic
D. Hyperplastic

Explanation: ### Explanation **Correct Option: A. Anaplastic** Anaplasia is defined as a lack of differentiation and is considered a hallmark of malignancy [1]. The term literally means "to form backward," implying a reversal from a specialized functional cell to a primitive, stem-cell-like phenotype. Anaplastic cells lose the structural and functional characteristics of their tissue of origin, making them resemble **undifferentiated mesenchymal or precursor cells** [1]. Key morphological features include cellular and nuclear pleomorphism, an increased nuclear-to-cytoplasmic (N:C) ratio, hyperchromasia, and a **high mitotic rate** with atypical (tripolar or quadripolar) mitotic figures [1]. **Why other options are incorrect:** * **B. Dysplastic:** Dysplasia refers to disordered growth and maturation of an epithelium [1]. While it involves increased mitosis and loss of uniformity, the cells still retain some features of the parent tissue and have not yet reached the "undifferentiated" state seen in anaplasia. * **C. Metaplastic:** Metaplasia is a reversible change where one adult cell type is replaced by another adult cell type (e.g., Squamous metaplasia in the bronchus) [1]. The cells are fully differentiated, just of a different type. * **D. Hyperplastic:** Hyperplasia is an increase in the number of cells in an organ or tissue. These cells are morphologically normal and fully differentiated. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark of Malignancy:** Anaplasia is the most reliable indicator of malignancy (along with metastasis). * **Tumor Giant Cells:** These are often seen in anaplastic tumors; they possess a single large polymorphic nucleus or multiple nuclei (not to be confused with inflammatory Langhans giant cells) [1]. * **Polarity:** Anaplastic cells show a complete loss of polarity; they grow in disorganized, sheet-like patterns rather than structured layers or glands. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 276-280.

Question 465: Which of the following is a wrong association?

A. Human Papillomavirus (HPV) - Cervical Carcinoma (CaCx)
B. Epstein-Barr Virus (EBV) - Burkitt's Lymphoma
C. Human Herpesvirus 8 (HHV-8) - Kaposi Sarcoma
D. Cytomegalovirus (CMV) - Nasopharyngeal Carcinoma (Correct Answer)

Explanation: **Explanation:** The correct answer is **D**, as **Cytomegalovirus (CMV)** is not the causative agent for Nasopharyngeal Carcinoma. Instead, **Epstein-Barr Virus (EBV)** is strongly associated with Nasopharyngeal Carcinoma (specifically the undifferentiated type) [1], [2], as well as Burkitt’s lymphoma and Hodgkin’s lymphoma. CMV is more commonly associated with opportunistic infections in immunocompromised patients (e.g., CMV retinitis or pneumonitis) but is not a recognized primary oncogenic virus in humans. **Analysis of other options:** * **Option A (HPV - CaCx):** This is a correct association. High-risk strains **HPV 16 and 18** are responsible for approximately 70% of cervical cancers via the action of oncoproteins **E6** (inhibits p53) and **E7** (inhibits RB) [1], [4]. * **Option B (EBV - Burkitt's Lymphoma):** This is a correct association [1]. EBV infects B-cells via the **CD21** receptor. In African (endemic) Burkitt’s lymphoma, EBV is found in nearly 100% of cases [3], often involving the **t(8;14)** translocation of the MYC gene. * **Option C (HHV-8 - Kaposi Sarcoma):** This is a correct association. HHV-8 (also known as KSHV) is the primary etiological agent for Kaposi Sarcoma, particularly in HIV/AIDS patients [5]. **High-Yield Clinical Pearls for NEET-PG:** * **HTLV-1:** Associated with Adult T-cell Leukemia/Lymphoma (ATLL) [1]. * **Hepatitis B & C:** Associated with Hepatocellular Carcinoma (HCC) [1]. * **H. pylori:** The only bacterium classified as a Class I carcinogen (associated with Gastric Adenocarcinoma and MALToma). * **Schistosoma haematobium:** Associated with Squamous Cell Carcinoma of the urinary bladder. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 744-745. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 220-221. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 334-335. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 261-262.

Question 466: An epidemiologic study of cancer deaths recorded in the last half of the 20th century is conducted. The number of deaths for one particular cancer had increased markedly in developed nations. More than 30% of cancer deaths in men, and more than 24% of cancer deaths in women, were caused by this neoplasm in 1998. In some nations, prevention strategies reduced deaths from this cancer. Which of the following neoplasms was most likely identified by this study?

A. Cerebral glioma
B. Bronchogenic carcinoma (Correct Answer)
C. Hepatocellular carcinoma
D. Colonic adenocarcinoma

Explanation: **Explanation:** **1. Why Bronchogenic Carcinoma is Correct:** The data provided (30% of cancer deaths in men and 24% in women) aligns perfectly with the epidemiological peak of **Lung Cancer (Bronchogenic Carcinoma)** in the late 20th century [1]. During the latter half of the 1900s, lung cancer became the leading cause of cancer-related mortality worldwide due to the delayed effects of the widespread increase in cigarette smoking [1]. The "prevention strategies" mentioned refer to public health anti-smoking campaigns, which led to a significant decline in incidence and mortality in developed nations starting in the late 1980s for men and slightly later for women [1], [3]. **2. Why Other Options are Incorrect:** * **Cerebral Glioma:** While aggressive, these are relatively rare and do not account for a high percentage of total cancer deaths. * **Hepatocellular Carcinoma:** This is more prevalent in developing nations (linked to HBV/HCV) rather than being the primary driver of mortality trends in developed nations during this period. * **Colonic Adenocarcinoma:** This is the second or third leading cause of cancer death, but its mortality rates have remained relatively stable or gradually declined due to screening; it never reached the 30% mortality threshold described [3]. **3. NEET-PG High-Yield Pearls:** * **Most common cancer (Incidence) Worldwide:** Breast Cancer (surpassed Lung in 2020). * **Most common cause of Cancer Death (Mortality) Worldwide:** Lung Cancer (in both men and women) [1]. * **In India:** The most common cancer in **men** is Lip/Oral cavity; in **women**, it is Breast cancer. * **Smoking Link:** 90% of lung cancers occur in smokers [1]. **Squamous cell carcinoma** and **Small cell carcinoma** have the strongest association with smoking [2]. * **Most common type:** Adenocarcinoma is now the most common histological subtype of lung cancer globally. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 719-720. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 284-286.

Question 467: Spindle cell carcinoma is a variant of which type of carcinoma?

A. Pleomorphic adenoma
B. Adenoid cystic carcinoma
C. Basal cell carcinoma
D. Squamous cell carcinoma (Correct Answer)

Explanation: **Spindle Cell Carcinoma (SpCC)**, also known as sarcomatoid carcinoma, is a highly aggressive variant of **Squamous Cell Carcinoma (SCC)**. It is characterized by a biphasic appearance: it contains traditional squamous cell elements alongside a predominant population of malignant spindle-shaped cells. This occurs due to **epithelial-mesenchymal transition (EMT)**, where epithelial cells lose their polarity and cell-cell adhesion, gaining mesenchymal characteristics. **Why the correct answer is right:** In SpCC, the tumor cells undergo dedifferentiation, mimicking the appearance of a sarcoma (spindle cells). However, immunohistochemistry (IHC) reveals that these spindle cells are positive for epithelial markers like **Cytokeratin (CK)** and **p63**, confirming their origin from squamous epithelium. It is most commonly found in the upper aerodigestive tract (larynx, oral cavity) and the skin [1]. **Analysis of incorrect options:** * **Pleomorphic Adenoma:** This is a benign mixed tumor of the salivary glands. While it contains both epithelial and mesenchymal-like (myxoid/chondroid) components, it is not a "spindle cell carcinoma." * **Adenoid Cystic Carcinoma:** A malignant salivary gland tumor characterized by a "cribriform" or "Swiss-cheese" pattern, not a spindle cell morphology. * **Basal Cell Carcinoma (BCC):** BCC typically presents with nests of basaloid cells showing peripheral palisading. While variants like "fibroepithelioma of Pinkus" exist, SpCC is specifically a variant of SCC [1]. **NEET-PG High-Yield Pearls:** * **IHC Marker:** Spindle cell carcinoma is often positive for **Vimentin** (mesenchymal marker) but must show positivity for **Cytokeratin** to be diagnosed as a carcinoma. * **Common Site:** The **Larynx** (glottis) is a classic site for SpCC, often presenting as a polypoid mass. * **Differential Diagnosis:** It must be distinguished from true sarcomas (like Fibrosarcoma) using IHC. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Disorders Involving Inflammatory And Haemopoietic Cells, pp. 644-645.

Question 468: Which is the most common cause of cancer-related death?

A. Oral cancer
B. Breast cancer
C. Prostate cancer
D. Lung cancer (Correct Answer)

Explanation: **Explanation:** **Lung cancer** is the leading cause of cancer-related mortality worldwide and in most developed nations, for both men and women [1]. The high mortality rate is attributed to the fact that lung cancer is often asymptomatic in its early stages, leading to late-stage diagnosis when curative treatment is no longer feasible. Additionally, it has a high propensity for early metastasis [3] and a relatively poor five-year survival rate compared to other common cancers [1]. **Analysis of Options:** * **Oral Cancer:** While highly prevalent in India due to tobacco and betel nut chewing, it is a leading cause of *morbidity* and the most common cancer in Indian males, but it does not surpass lung cancer in total global mortality. * **Breast Cancer:** This is the most common *incident* cancer (most frequently diagnosed) among women globally [2]. However, due to effective screening (mammography) and advanced hormonal/targeted therapies, the mortality rate is lower than that of lung cancer [1], [2]. * **Prostate Cancer:** This is the most common cancer diagnosed in men (excluding skin cancer) in many Western countries [2]. However, it is often slow-growing with a very high survival rate, making it a less frequent cause of death compared to lung cancer [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cancer (Incidence) Worldwide:** Breast Cancer (recently surpassed Lung Cancer). * **Most common cancer (Incidence) in India:** Breast Cancer (Overall), Oral Cancer (Males), Cervical/Breast Cancer (Females). * **Most common cause of cancer death (Mortality) Worldwide:** Lung Cancer [1]. * **Most common cause of cancer death in India:** Lung Cancer (Males), Breast Cancer (Females). * **Key Risk Factor:** Tobacco smoking is responsible for approximately 80-90% of lung cancer deaths [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 719-720. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 284-286. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-725.

Question 469: Hepatocellular carcinoma is caused by which of the following?

A. Fumonisins
B. Aflatoxin (Correct Answer)
C. Ochratoxin
D. Trichothecenes

Explanation: **Explanation:** **Hepatocellular Carcinoma (HCC) and Aflatoxin** The correct answer is **Aflatoxin**, specifically **Aflatoxin B1**. It is a potent hepatocarcinogen produced by the fungi *Aspergillus flavus* and *Aspergillus parasiticus*, which commonly contaminate stored grains, corn, and peanuts in humid climates [1]. * **Mechanism:** Aflatoxin B1 undergoes metabolic activation in the liver to form a reactive epoxide [2]. This metabolite causes a specific **transversion mutation (G:C to T:A)** at **codon 249** of the **TP53 gene** [2]. This inactivation of the p53 tumor suppressor protein leads to uncontrolled cell proliferation and the development of HCC. There is a synergistic effect when Aflatoxin exposure co-exists with Chronic Hepatitis B (HBV) infection [1]. [3] **Analysis of Incorrect Options:** * **A. Fumonisins:** Produced by *Fusarium verticillioides*, these are linked to esophageal cancer and neural tube defects, but not primarily HCC. * **C. Ochratoxin:** Produced by *Aspergillus* and *Penicillium* species, Ochratoxin A is primarily **nephrotoxic** and is associated with Balkan Endemic Nephropathy and transitional cell carcinoma of the urinary tract. * **D. Trichothecenes:** These are fungal toxins (e.g., T-2 toxin) that inhibit protein synthesis. They cause acute gastrointestinal symptoms and bone marrow suppression (Alimentary Toxic Aleukia) rather than malignancy. **High-Yield Clinical Pearls for NEET-PG:** * **Most common mutation in HCC (Global):** TP53. * **Aflatoxin Signature:** TP53 mutation at codon 249 (Arginine to Serine) [2]. * **Tumor Marker for HCC:** Alpha-fetoprotein (AFP). * **Vinyl Chloride:** Associated with Angiosarcoma of the liver, not HCC. * **Arsenic:** Associated with both HCC and Angiosarcoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 331-332. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 215-216.

Question 470: All of the following are recognized tumor markers except?

A. Beta HCG
B. Beta 2 microglobin (Correct Answer)
C. Acid phosphatase
D. Alpha fetoprotein

Explanation: **Explanation:** The correct answer is **B. Beta 2 microglobulin**. While Beta 2 microglobulin (B2M) is often associated with certain malignancies, it is technically classified as a **prognostic marker** rather than a diagnostic tumor marker [5]. It is a component of the MHC Class I molecule found on all nucleated cells. Elevated levels are seen in Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), and Lymphomas, where they correlate with tumor burden and renal function, helping to stage the disease rather than identify the specific tumor type. **Analysis of other options:** * **A. Beta HCG:** A classic oncofetal antigen used as a highly specific tumor marker for Gestational Trophoblastic Disease (Hydatidiform mole/Choriocarcinoma) and certain Germ Cell Tumors (e.g., Dysgerminoma, Embryonal carcinoma) [3]. * **C. Acid Phosphatase:** Specifically, Prostatic Acid Phosphatase (PAP) was the primary tumor marker for Prostate Cancer before the advent of PSA [1]. Though less sensitive than PSA, it remains a recognized enzyme-based tumor marker. * **D. Alpha-fetoprotein (AFP):** A major oncofetal antigen used to screen for and monitor Hepatocellular Carcinoma (HCC) and Non-seminomatous Germ Cell Tumors (specifically Yolk Sac Tumors) [2], [4]. **Clinical Pearls for NEET-PG:** * **Most specific marker for Pancreatic Cancer:** CA 19-9. * **Marker for Medullary Carcinoma of Thyroid:** Calcitonin. * **Ovarian Cancer marker:** CA-125 (also elevated in endometriosis and PID). * **B2M Significance:** In Multiple Myeloma, B2M is the most important prognostic factor in the International Staging System (ISS). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 346. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 254-255. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 512-513. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 319-320. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 318-319.

Practice by Chapter

Nomenclature and Classification of Tumors

Practice Questions

Characteristics of Benign and Malignant Neoplasms

Practice Questions

Molecular Basis of Cancer

Practice Questions

Carcinogenesis and Carcinogens

Practice Questions

Tumor Progression and Metastasis

Practice Questions

Tumor Markers

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Genetic Basis of Cancer

Practice Questions

Tumor Immunity

Practice Questions

Cancer Epidemiology and Prevention

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?